Professor Peter Sasieni Academics Academic Director of King's Clinical Trials Unit Contact details peter.sasieni@kcl.ac.uk
Antiretroviral therapy alone versus antiretroviral therapy with a kick and kill approach, on measures of the HIV reservoir in participants with recent HIV infection (the RIVER trial): a phase 2, randomised trial 14 March 2020 Population-level impact of human papillomavirus vaccination 08 February 2020 Absolute risks of cervical precancer among women who fulfill exiting guidelines based on HPV and cytology cotesting 01 February 2020 High-dose oral vitamin D supplementation and mortality in people aged 65-84 years: the VIDAL cluster feasibility RCT of open versus double-blind individual randomisation 01 February 2020 Development and validation of a risk prediction model to diagnose Barrett's oesophagus (MARK-BE): a case-control machine learning approach 01 January 2020 Errors in determination of net survival: cause-specific and relative survival settings 01 January 2020 Current status of human papillomavirus vaccination in India's cervical cancer prevention efforts 01 November 2019 Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study 01 November 2019 The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome 01 October 2019 Benefits and harms in the National Lung Screening Trial: expected outcomes with a modern management protocol 01 August 2019
21 January 2020 HPV vaccine almost eradicates risk of cervical cancer in young women, analysis suggests A recently published report on the HPV vaccination underestimated the effect of the regime as a new…